Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1173 participants.
Also called NCT02433379
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 1,173 participants
- Sponsor
- Registry
-
NCT02433379
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Poland, Puerto Rico, Spain, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02433379. Allocation not applicable; no masking; primary purpose supportive care. Start 2015-06-09 (actual); primary completion 2019-12-06 (actual). Results posted on 2021-01-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
- Acronym
- UNTOUCHED
- Condition
- Ventricular Fibrillation
- Condition
- Ventricular Tachycardia
- Condition
- Low Cardiac Output
- Intervention (Device)
- EMBLEM S-ICD System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct02433379- Content hash
506f220843fe980a8340f1e7f6bcf9944ce8a0d13d136a7112e532369024a766